Sands Capital Ventures as of March 31, 2023
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 23 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dice Therapeutics | 19.5 | $79M | 2.7M | 28.65 | |
| Uipath Cl A (PATH) | 16.6 | $67M | 3.8M | 17.56 | |
| Samsara Com Cl A (IOT) | 11.2 | $45M | 2.3M | 19.72 | |
| Nu Hldgs Ord Shs Cl A (NU) | 10.8 | $44M | 9.2M | 4.76 | |
| Doordash Cl A (DASH) | 9.5 | $38M | 604k | 63.56 | |
| Snowflake Cl A (SNOW) | 8.2 | $33M | 216k | 154.29 | |
| 10x Genomics Cl A Com (TXG) | 6.6 | $27M | 482k | 55.79 | |
| Acrivon Therapeutics Common Stock (ACRV) | 5.2 | $21M | 1.7M | 12.69 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 3.9 | $16M | 706k | 22.53 | |
| Acumen Pharmaceuticals (ABOS) | 3.4 | $14M | 3.4M | 4.06 | |
| Karuna Therapeutics Ord | 2.6 | $11M | 59k | 181.64 | |
| Tarsus Pharmaceuticals (TARS) | 0.8 | $3.3M | 260k | 12.57 | |
| 908 Devices (MASS) | 0.7 | $2.8M | 326k | 8.60 | |
| Spruce Biosciences (SPRB) | 0.4 | $1.7M | 787k | 2.21 | |
| Candel Therapeutics (CADL) | 0.3 | $1.1M | 812k | 1.35 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $580k | 725k | 0.80 | |
| Crowdstrike Hldgs Cl A (CRWD) | 0.0 | $119k | 864.00 | 137.26 | |
| Coupang Cl A (CPNG) | 0.0 | $112k | 7.0k | 16.00 | |
| Absci Corp (ABSI) | 0.0 | $101k | 58k | 1.75 | |
| Datadog Cl A Com (DDOG) | 0.0 | $99k | 1.4k | 72.66 | |
| Toast Cl A (TOST) | 0.0 | $80k | 4.5k | 17.75 | |
| Confluent Class A Com (CFLT) | 0.0 | $33k | 1.4k | 24.07 | |
| Gitlab Class A Com (GTLB) | 0.0 | $23k | 658.00 | 34.29 |
